Martingale Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.11M | Sell |
10,546
-2,650
| -20% | -$787K | 0.08% | 251 |
|
|
2025
Q4 | $3.6M | Sell |
13,196
-2,001
| -13% | -$544K | 0.09% | 200 |
|
|
2025
Q3 | $4.11M | Sell |
15,197
-2,199
| -13% | -$598K | 0.1% | 174 |
|
|
2025
Q2 | $4.79M | Buy |
17,396
+5,182
| +42% | +$1.41M | 0.12% | 152 |
|
|
2025
Q1 | $3.24M | Buy |
12,214
+210
| +2% | +$51.8K | 0.08% | 195 |
|
|
2024
Q4 | $2.79M | Buy |
12,004
+973
| +9% | +$224K | 0.07% | 228 |
|
|
2024
Q3 | $2.43M | Sell |
11,031
-5,670
| -34% | -$1.17M | 0.06% | 265 |
|
|
2024
Q2 | $3.28M | Sell |
16,701
-320
| -2% | -$66.1K | 0.07% | 198 |
|
|
2024
Q1 | $3.66M | Buy |
17,021
+3,126
| +22% | +$657K | 0.07% | 193 |
|
|
2023
Q4 | $2.93M | Buy |
13,895
+7,161
| +106% | +$1.53M | 0.06% | 212 |
|
|
2023
Q3 | $1.35M | Buy |
6,734
+4,824
| +253% | +$959K | 0.03% | 354 |
|
|
2023
Q2 | $354K | Buy |
+1,910
| New | +$353K | 0.01% | 673 |
|
|
2022
Q4 | – | Sell |
-1,134
| Closed | -$201K | – | 834 |
|
|
2022
Q3 | $201K | Hold |
1,134
| – | – | ﹤0.01% | 781 |
|
|
2022
Q2 | $233K | Sell |
1,134
-1
| -0.1% | -$212 | ﹤0.01% | 781 |
|
|
2022
Q1 | $270K | Buy |
+1,135
| New | +$267K | ﹤0.01% | 745 |
|
|
2021
Q3 | – | Sell |
-9,738
| Closed | -$2.07M | – | 861 |
|
|
2021
Q2 | $2.07M | Sell |
9,738
-23,614
| -71% | -$4.99M | 0.02% | 249 |
|
|
2021
Q1 | $6.81M | Sell |
33,352
-8,481
| -20% | -$1.67M | 0.08% | 182 |
|
|
2020
Q4 | $7.62M | Buy |
41,833
+28,782
| +221% | +$4.89M | 0.09% | 190 |
|
|
2020
Q3 | $2.18M | Buy |
13,051
+3,100
| +31% | +$522K | 0.03% | 393 |
|
|
2020
Q2 | $1.62M | Buy |
9,951
+100
| +1% | +$17.9K | 0.02% | 597 |
|
|
2020
Q1 | $1.7M | Buy |
9,851
+3,794
| +63% | +$755K | 0.02% | 525 |
|
|
2019
Q4 | $1.22M | Buy |
6,057
+1,500
| +33% | +$308K | 0.01% | 718 |
|
|
2019
Q3 | $964K | Buy |
4,557
+140
| +3% | +$29.3K | 0.01% | 779 |
|
|
2019
Q2 | $859K | Sell |
4,417
-4,099
| -48% | -$756K | 0.01% | 807 |
|
|
2019
Q1 | $1.4M | Buy |
+8,516
| New | +$1.51M | 0.02% | 690 |
|
|
2014
Q1 | – | Sell |
-5,984
| Closed | -$470K | – | 884 |
|
|
2013
Q4 | $470K | Sell |
5,984
-2,416
| -29% | -$189K | 0.02% | 786 |
|
|
2013
Q3 | $621K | Hold |
8,400
| – | – | 0.02% | 697 |
|
|
2013
Q2 | $638K | Buy |
+8,400
| New | +$551K | 0.02% | 676 |
|
Other funds holding CME
VCM
VPM
Martingale Asset Management's CME Position: Q1 2026 in Review
Martingale Asset Management reduced its CME Group (CME) stake by 20% in Q1 2026, selling an estimated $787K and leaving 10,546 shares worth $3.11M. The position accounts for 0.08% of the portfolio, ranked #251.
Martingale Asset Management first reported a position in CME in Q2 2013 and has held it in 28 quarters since. The position peaked at $7.62M in Q4 2020. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Martingale Asset Management held 10,546 shares of CME Group worth $3.11M as of Q1 2026.
- Martingale Asset Management sold 2,650 CME Group shares in Q1 2026, an estimated $787K.
- CME Group made up 0.08% of Martingale Asset Management's portfolio in Q1 2026, its #251 holding.
- Martingale Asset Management first reported a position in CME Group in Q2 2013 and has held it in 28 quarters since.
- Martingale Asset Management's CME Group position peaked at $7.62M in Q4 2020.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.